World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
33230
World Ranking
19269
National Ranking
9596

Keith D. Dawkins publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Keith D. Dawkins sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 326 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Keith D. Dawkins D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Keith D. Dawkins sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Keith D. Dawkins is a researcher affiliated with Boston Scientific in the United States. Their work focuses primarily on the field of Medicine with published contributions also found in related subfields such as Surgery, Cardiology and Cardiovascular Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics of Dawkins' research include:

  • Coronary Interventions and Diagnostics
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics

The researcher has published work in the European Journal of Preventive Cardiology, marking a presence in that specific publication venue.

One notable paper authored by Dawkins is titled "Ten-year all-cause mortality according to smoking status in patients with severe coronary artery disease undergoing surgical or percutaneous revascularization", published in 2020 in the European Journal of Preventive Cardiology with 16 citations to date.

Frequent collaborators in Dawkins' research include:

  • Kuniaki Takahashi
  • Daniel J.F.M. Thuijs
  • Chao Gao
  • Masafumi Ono
  • David R. Holmes

Best Publications

  • Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

    Patrick W. Serruys;Marie-Claude Morice;A. Pieter Kappetein;Antonio Colombo

  • The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease.

    Sianos G;Morel Ma;Kappetein Ap;Morice Mc

  • Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease : 5-year follow-up of the randomised, clinical SYNTAX trial

    Friedrich W. Mohr;Marie Claude Morice;A. Pieter Kappetein;Ted E. Feldman

  • Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents

    Gregg W. Stone;Jeffrey W. Moses;Stephen G. Ellis;Joachim Schofer

  • Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II

    Vasim Farooq;David Van Klaveren;Ewout W. Steyerberg;Emanuele Meliga

  • Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Assessment of the SYNTAX score in the Syntax study

    Patrick W. Serruys;Yoshinobu Onuma;Scot Garg;Giovanna Sarno

  • Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction

    Anthony H. Gershlick;Amanda Stephens-Lloyd;Sarah Hughes;Keith R. Abrams

  • Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial

    Arie Pieter Kappetein;Ted E. Feldman;Michael J. MacK;Marie Claude Morice

  • Five-Year Outcomes in Patients With Left Main Disease Treated With Either Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Trial

    Marie Claude Morice;Patrick W. Serruys;A. Pieter Kappetein;Ted E. Feldman

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation.

    Conor M. Burke;James Theodore;Keith D. Dawkins;Samuel A. Yousem

  • Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice

    Keith D. Dawkins;Eberhard Grube;Giulio Guagliumi;Adrian P. Banning

  • Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial

    Arie Pieter Kappetein;Stuart J. Head;Marie-Claude Morice;Adrian P. Banning

  • Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial

    Stuart J. Head;Piroze M. Davierwala;Patrick W. Serruys;Simon R. Redwood

  • Diabetic and Nondiabetic Patients With Left Main and/or 3-Vessel Coronary Artery Disease Comparison of Outcomes With Cardiac Surgery and Paclitaxel-Eluting Stents

    Adrian P. Banning;Stephen Westaby;Marie-Claude Morice;A. Pieter Kappetein

  • Quality of Life after PCI with Drug-Eluting Stents or Coronary-Artery Bypass Surgery

    David J. Cohen;Ben Van Hout;Patrick W. Serruys;Friedrich W. Mohr

  • Quantification of Incomplete Revascularization and its Association With Five-Year Mortality in the Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery (SYNTAX) Trial Validation of the Residual SYNTAX Score

    Vasim Farooq;Patrick W. Serruys;Christos V. Bourantas;Yaojun Zhang

  • A New Tool for the Risk Stratification of Patients With Complex Coronary Artery Disease The Clinical SYNTAX Score

    Scot Garg;Giovanna Sarno;Hector M. Garcia-Garcia;Chrysafios Girasis

  • Cyphering the Complexity of Coronary Artery Disease Using the Syntax Score to Predict Clinical Outcome in Patients With Three-Vessel Lumen Obstruction Undergoing Percutaneous Coronary Intervention

    Marco Valgimigli;Patrick Washington Serruys;Keiichi Tsuchida;Sophia Vaina

Frequent Co-Authors

Patrick W. Serruys
Patrick W. Serruys University of Galway
Antonio Colombo
Antonio Colombo Humanitas Clinical and Research Center IRCCS
Friedrich W. Mohr
Friedrich W. Mohr Leipzig University
Ted Feldman
Ted Feldman Edwards Lifesciences (United States)
David R. Holmes
David R. Holmes Mayo Clinic
Gregg W. Stone
Gregg W. Stone Icahn School of Medicine at Mount Sinai
Eberhard Grube
Eberhard Grube University Hospital Bonn
Stephen G. Ellis
Stephen G. Ellis Cleveland Clinic
Jeffrey J. Popma
Jeffrey J. Popma Beth Israel Deaconess Medical Center
Michael J. Mack
Michael J. Mack Scott & White Memorial Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about alternative pathways to a career in healthcare? Online health and medical degrees are becoming increasingly popular for their flexibility and affordability—perfect for those wanting to study while working or managing other responsibilities.

For students interested in data and technology within healthcare, a health information management degree online can open doors to roles in health data analysis, patient records, and compliance. If you’re looking for quick entry into the field, consider enrolling in one of the cheapest medical billing and coding online courses to start a career in administrative support for clinics and hospitals.

Nursing remains a high-demand field in the USA. Prospective nurse practitioners can access the cheapest np programs online to become trusted advanced practice providers. Registered nurses aiming for leadership and specialized roles might be interested in the cheapest online msn programs to take their qualifications a step further.

These online programs provide accessible, affordable career pathways into the US healthcare system—offering diverse roles beyond traditional medical degrees.

Best Scientists Citing Keith D. Dawkins

Trending Scientists